Current perspectives on anti-aging interventions

Letters in Drug Design and Discovery

Volumn 7, Issue 5, 2010, Pages 379-388

  Rizvi, Syed Ibrahim ^a   Jha, Rashmi ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Anti aging; Anti oxidant supplementation; Caloric restriction

Indexed keywords

ACETYLCARNITINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CARNOSINE; CAROTENE; CHOLINE ALFOSCERATE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GLUTATHIONE; GROWTH HORMONE; MELATONIN; MITOCHONDRIAL DNA; PRASTERONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; THIOCTIC ACID; THYROTROPIN;

AGING; APOPTOSIS; ARTICLE; CALORIC RESTRICTION; CELL THERAPY; DIET SUPPLEMENTATION; DNA DAMAGE; DNA REPAIR; DRUG RESEARCH; GENETIC ENGINEERING; HORMONAL THERAPY; HUMAN; LIFESPAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TEA; TELOMERE;

EID: 77953706294     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010791163488     Document Type: Article

References (159)

1. Kregel, K.C.; Zhange, H.J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects and pathological considerations. Am. J. Physiol. Requl. Integr. Comp. Physiol., 2007, 292(1), 18-36.
2. Cartor, C.S.; Hofes, T.; Seo, A.Y.; Leeuwenburgh, C. Mechanism of life and health span. Role of calorie restriction and exercise intervention. Appl. Phiol. Nutr. Metab., 2007, 32 (5), 954-966.
3. Medawar, P.B. An unsolved problem of Biology, H.K. Lewis: London, 1952.
4. Rattan, S.I. Ageing, gerentogenes and hormesis. Indian J. Exp. Biol., 2000, 38, 1-5.
5. Rattan, S.I. Antiageing strategies: prevention of theory? EMBO Rep., 2005, 6, 25-29.
6. Rattan, S.I. Biogerentology: the next step. Ann. N.Y. Acad. Sci., 2000, 908, 282-290.
7. Yin, D.; Chen, K. The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp. Gerontol., 2005, 40, 455-65.
8. Kanungo, M.S. Genes and aging, Cambridge: Cambridge university press, 1994.
9. Vijg, J. Somatic mutations and aging: a reevaluation. Mut. Res., 2000, 447, 117-35.
10. Holliday, R. The current status of the protein error theory of aging. Exp. Gerontol., 1996, 31, 449-452.
11. Franceschi, C.; Valensin, S.; Bonafe, M.; Paolisso, G.; Yashin, A.I.; Monti, D.; De Benedictis, G. The network and remodeling theories of aging: historical background and new perspectives. Exp. Gerontol., 2000, 16, 44-51.
12. Harley, C.B.; Vaziri, H.; Counter, C.M.; Allsopp, R.C. The telomere hypothesis of cellular aging. Exp. Gerontol., 1992, 27, 375-382.
13. Olovnikov, A.M. Telomeres, Telomerase and aging: origin of the theory. Exp. Gerontol., 1996, 31, 443-448.
14. Harman, D. Free radical theory of ageing; an update: increasing the functional life span. Ann. N.Y. Acad. Sci., 2006, 1067, 10-21.
15. Sohal, R.S.; Weindruch, R. Oxidative stress,calorie restriction and ageing. Science, 1996, 273, 59-63.
16. Tosato, M.; Zamboni, V.; Ferrini, A.; Cesari, M. The aging process and potential interventions to extend life expectancy. Clin. Interv. Aging, 2007, 2(3), 401-412.
17. Wong, T.P. An Old Question Revisited: Current Understanding of Aging Theories. MJM, 2001, 6, 41-47.
18. Beckman, K.B.; Ames, B.N. The free radical theory of Aging Matures. Physiol. Rev., 1998, 78, 547-581.
19. Ames, B.N.; Shigenaga, M.K.; Hogen, T.M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA, 1993, 90, 7915-7921.
20. Ishii, N.; Senoo-Matsuda, N.; Miyake, K.; Yasuda, K.; Ishii, T.; Hartman, P.S.; Furukawa, S. Coenzyme Q10 can prolong C. elegans lifespan by lowering oxidative stress. Mech. Ageing Dev., 2004, 125, 41-46.
21. Rong, Y.; Doctrow, S.R.; Tocco, G.; Baudry, M. EUK-134, a synthetic superoxide dismutse and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc. Natl. Acad. Sci., 1999, 96, 9897-9902.
22. Melov, S.; Ravenscroft, J.; Malik, S.; Gill, M.S.; Walker, D.W.; Clayton, P.E.; Wallace, D.C.; Malfroy, B.; Doctrow, S.R.; Lithgow, G.J. Extension of lifespan with superoxide dismutase/catalase mimetics. Science, 2000, 289, 1567-1569.
23. Keaney, M.; Gems, D. No increase in lifespan in Caenorhabditis elegans upon treatment with the superoxide dismutase mimetic EUK-8. Free Radic. Biol. Med., 2003, 34, 277-282.
24. Keaney, M.; Matthijssens, F.; Sharpe, M.; Vanfleteren, J.; Gems, D. Superoxide dismutase mimetics elevate superoxide dismutase activity in vivo but do not retard aging in the nematode Caenorhabditis elegans. Free Radic. Biol. Med., 2004, 37, 239-250.
25. Segasothy, M.; Phillips, P.A. Vegetarian diet: panacea for modern lifestyle diseases? Q J. Med., 1999, 92(9), 531-544.
26. Rice, M.E. Ascorbate regulation and its neuroprotective role in the rat brain. Trends Neurosci., 2000, 23, 209-216.
27. McCay, P.B. Vitamin E: interactions with free radicals and ascorbate. Annu. Rev. Nutr., 1985, 5, 322-340.
28. Bagi, Z.; Cseko, C.; Toth, E.; Koller, A. Oxidative stress-induced dysregulation of arteriosal wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment. Am. J. Physiol. Heart Circ. Physiol., 2003, 285, 2277-2783.
29. Steinberg, D. Oxidative modification of LDL and atherogenesis. Circulation, 1997, 95, 1062-1071.
30. Morrow, J.D.; Roberts, L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res., 1997, 36, 1-21.
31. Upritchard, J.E.; Schuurman, C.R.; Wiersma, W.C.; Tijburg, L.B.; Coolen, S.A.; Rijken, P.J.; Wiseman, S.A. Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults. Am. J. Clin. Nutr., 2003, 78, 985-992.
32. Liu, T.; Stern, A.; Roberts, L.J.; Morrow, J.D. The isoprostanes: novel prostaglandin- like products of the free radical-catalyzed per-oxidation of arachidonic acid. J. Biomed. Sci., 1999, 6, 226-235.
33. Abuja, P.M. When might an antioxidant become a prooxidant? Acta. Anaesthesiol. Scand., 1998, 42(Suppl 112), 229-230.
34. Berger, M.M. Can oxidative damage be treated nutritionally? Clin. Nutr., 2005, 24, 172-183.
35. Neuzil, J.; Darlow, B.A.; Inder, T.E.; Sluis, K.B.; Winterbourn, C.C.; Stocker, R. Oxidation of parental lipid emulsions by ambient and phototherapy lights: potential toxicity of routine parenteral feeding. J. Pediatr., 1995, 126, 785-790.
36. Kaliora, A.C.; Dedoussis, G.V.; Schmidt, H. Dietary antioxidnats in preventing atherogenesis. Atherosclerosis, 2006, 187(1), 1-17.
37. Vivekananthan, D.P.; Penn, M.S.; Sapp, S.K.; Hsu, A.; Topol, E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet, 2003, 361, 2017-2023.
38. Lee, I.M.; Cook, N.R.; Gaziano, M.; Gordon, D.; Ridker, P.M.; Manson, J.E.; Hennekens, C.H.; Buring, J.E. Vitamin E in the prevention of cardiovascular disease and cancer - The Women's Health Study: a randomized controlled trial. JAMA, 2005, 294, 56-65.
39. Vina, J.; Lloret, A.; Orti, R.; Alonso, D. Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress. Mol. Asp. Med., 2004, 25(1-2), 117-123.
40. Luchsinger, J.A.; Tang, M.X.; Shea, S.; Mayeux, R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch. Neurol., 2003, 60, 203-208.
41. Gao, X.; Bermudez, O.I.; Tucker, K.L. Plasma C-Reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic White elders. J. Nutr., 2004, 134, 913-918.
42. Hauer, K.; Hildebrandt, W.; Sehl, Y.; Edler, L.; Oster, P.; Droge, W. Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment. J. Mol. Med., 2003, 81, 118-125.
43. Avery, N.G.; Kaiser, J.L.; Sharman, M.J.; Scheett, T.P.; Barnes, D.M.; Gomez, A.L.; Pizzolatti, M.G.; Silva, F.R. Effects of vitamin E supplementationon recovery from repeated bouts of resistance exercise. J. Strength Cond. Res., 2003, 17(4), 801-809.
44. Miller, A.L. Antioxidant flavonoids;structure function and clinical use. Altern. Med. rev., 1996, 1(2), 103-110.
45. Cazarolli, L.H.; Zanatta, L.; Alberton, E.H.; Figueiredo, M.S.; Folador, P.; Damazio, R.G.; Pizzolatti, M.G.; Silva, F.R. Flavonoids: prospective drug candidates. Med. Chem., 2008, 8(13), 1429-1440.
46. Lee, E.R.; Kang, G.H.; Cho, S.G. Effect of flavonoids on human health: old subjects but new challenges. Recent Pat. Biotechnol., 2007, 1(2), 139-150.
47. Chin-Dusting, J.P.; Fisher, L.J.; Lewis, T.V.; Piekarska, A.; Nestel, P.J.; Husband, A. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br. J. Pharmacol., 2001, 133(4), 595-605.
48. Rice-Evans, C. Flavonoid antioxidants. Curr. Med. Chem., 2001, 8, 797-807.
49. Zilkens, R.R.; Puddey, I.B. Alcohol and cardiovascular disease-- more than one paradox to consider. Alcohol and type 2 diabetes-- another paradox? J. Cardiovasc. Risk., 2003, 10(1), 25-30.
50. Cooper, K.A.; Chopra, M.; Thurnham, D.I. Wine polyphenols and promotion of cardiac health. Nutr. Res. Rev., 2004, 17(1), 111-130.
51. Obisesan, T.O.; Hirsh, R.; Kosoko, O.; Carlson, L.; Parrott, M. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J. Am. Geriatr. Soc., 1998, 46, 1-7.
52. Orgogozo, J.M.; Dartigues, J.F.; Lafont, S.; Letenneur, L.; Commenges, D.; Salomon, R.; Renaud, S.; Breteler, M. B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol., 1997, 3, 185-192.
53. Maurya, P.K.; Rizvi, S.I. Protective role of tea catechins on erythrocytes subjected to oxidative stress during human aging. Natur. Prod. Res., 2008, 14, 1-8.
54. Kitani, K.; Osawa, T.; Yokozawa, T. The effects of tetrahydrocurcumin and green tea polyphenol on the survival of male C57BL/6 mice. Biogerontology, 2007, 8(5), 567-573.
55. Thangapazham, R.L.; Singh, A.K.; Sharma, A.; Warren, J.; Gaddipati, J.P.; Maheshwari, R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett., 2007, 245, 232-241.
56. Yang, C.S.; Lambert, J.D.; Hou, Z.; Ju, J.; Lu, G.; Hao, X. Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcin., 2006, 45, 431-435.
57. Rizvi, S.I.; Zaid, M.A.; Anis, R.; Mishra, N. Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clin. Exp. Pharmacol. Physiol., 2005, 32, 70-75.
58. Srividhya, R.; Jyothilakshmi, V.; Arulmathi, K.; Senthilkumaran, V.; Kalaiselvi, P. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-) epigallocatechin-3-gallate. Int. J. Dev. Neurosci., 2008, 26(2), 217-223.
59. Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and prooxidant behavior of flavonoids:structure-activity relationships. Free Radic. Biol. Med., 1997, 22(5), 749-760.
60. Van Acker, S.A.,; Van den Berg, D.J.; Tromp, M.N.; Griffioen, D.H.; Van Bennekom, W.P.; Van der Vijgh, W.J.; Bast, A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med., 1996, 20, 331-342.
61. Rizvi, S.I.; Jha, R.; Maurya, P.K. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res., 2006, 9, 470-474.
62. Rizvi, S.I.; Jha, R.; Pandey, K.B. Activation of erythrocyte plasma membrane redox system provides a useful method to evaluate antioxidant potential of plant polyphenols. In: Armstrong D, Ed.; Methods in Molecular Biology; Advanced Protocols in Oxidative Stress. New Jersy: Humana Press, 2010, vol. 594, pp. 341-348.
63. Rizvi, S.I.; Maurya, P.K. Markers of oxidative stress in erythrocytes during aging in humans. Ann. N. Y. Acad. Sci., 2007, 1100, 373-382.
64. Guo, Q.; Zhao, B.; Li, M.; Shen, S.; Xin, W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochem. Biophys. Acta, 1996, 1304(3), 210-222.
65. Ishige, K.; Schubert, D.; Sagara, Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med., 2001, 30(4), 433-446.
66. Chan, F.L.; Choi, H.L.; Chen, Z.Y.; Chan, P.S.; Huang, Y. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett., 2000, 160(2), 219-228.
67. Yamashita, N.; Kawanishi, S. Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin. Free Radic. Res., 2000, 33(5), 623-633.
68. Rucinska, A.; Kirko, S.; Gabryelak, T. Effect of the phytoestrogen, genistein-8-C-glucoside, on Chinese hamster ovary cells in vitro. Cell Biol. Int., 2007, 31(11), 1371-1378.
69. Galati, G.; Sabzevari, O.; Wilson, J.X.; O'Brien, P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology, 2002, 177, 91-104.
70. Howes, R.M. The free radical fantasy. The panoply of paradoxes. Ann. N.Y. Acad. Sci., 2006, 1067, 22-26.
71. Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L.; Valanis, B.; Williams, J.H.; Barnhart, S.; Hammar, S. Effects of a combinationof beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 1996, 334(18), 1150-1155.
72. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention; systematic review and metaanalysis. JAMA, 2007, 297 (8), 842-857.
73. Miller, E.R. III; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R.A.; Appel, L.J.; Guallar, E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med., 2005, 142, 37-46.
74. Fusco, D.; Colloca, G.; Lo Monaco, M.R.; Cesari, M. Effects of antioxidant supplementation on the aging process. Clin. Interv. Aging, 2007, 2(3), 377-387.
75. Ames, B.N.; Liu, J.; Atamna, H.; Hagen, T.M. Delaying the mitochondrial decay of aging in the brain. Clin. Neurosci. Res., 2003, 2, 331-338.
76. Calabrese, V.; Colombrita, C.; Sultana, R.; Scapagnini, G.; Calvani, M.; Butterfield, D.A.; Bast, A. Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function. Antioxid. Redox Signal., 2006, 8(3-4), 404-416.
77. Suchy, J.; Chan, A.; Shea, T.B. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophos phocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr. Res., 2009, 29(1), 70-74.
78. Parnetti, L.; Amenta, F.; Gallai, V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech. Ageing Dev., 2001, 122(16), 2041-2055.
79. Hipkiss, A.R.; Brownson, C. A possible new role for the Anti-Ageing peptide carnosine. Cell Mol. Life. Sci., 2000, 57(5), 747-753.
80. Hipkiss, A.R.; Brownson, C. Carnosine reacts with protein carbonyl groups: another possible role for the Anti-Ageing peptide? Biogerontol., 2000, 1(3), 217-223.
81. Leow, M.K.; Loh, K.C. Controversial endocrine interventions for the aged. Singapore Med. J., 2006, 47(7), 569-579.
82. Rudman, D.; Feller, A.G.; Nagraj, H.S. Effect of human growth hormone in men over 60 years old. N. Eng. J. Med., 1990, 323, 1-6.
83. Blackman, M.R.; Sorkin, J.D.; Munzer, T.; Bellantoni, M.F.; Busby-Whitehead, J.; Stevens, T.E.; Jayme J, O'Connor, K.G.; Christmas, C.; Tobin, J.D.; Stewart, K.J.; Cottrell, E.; St Clair, C.; Pabst, K.M.; Harman, S.M. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA, 2002, 288(18), 2282-2292.
84. Arlt, W. Dehydroepiandrosterone and aging. Best Pract. Res. Clin. Endocrinol. Metab., 2004, 18(3), 363-380.
85. Legrain, S.; Girard, L. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging, 2003, 20(13), 949-967.
86. Lucas, J.A.; Ahmed, S.A.; Casey, L.M.; Macdonald, P.C. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F(1) mice fed dehydroepiandrosterone. J. Clin. Inves., 1985, 75, 2091-2093.
87. Schwartz, A.G.; Whitcomb, J.M.; Nyce, J.W. Dehydroepiendrosterone and structural analogs: A new class of cancer chemopreventive agents. Adv. Cancer Res., 1988, 51, 391-424.
88. Labrie, F.; Belanger, A.; Van, L.T.; Labrie, C.; Simard, J.; Cusan, L.; Gomez, J.L.; Candas, B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids, 1998, 63, 322-328.
89. Morales, A.J.; Nodan, J.J.; Nelson, J.C.; Yen, S. Effect of replace- ment dose of dehydroepiendosterone in men and women of advancing age. J. Clin. Endrocrinol. Metab., 1994, 78, 1360-1367.
90. Flynn, M.A.; Weaver-Osterhotz, D.; Sharpe-Timms, K.L.; Allen, S.; Krause, G. Dehydroepiendrosterone replacement in aging humans. J. Clin. Endrocrinol. Metb. 1999, 84(5), 1527-1533.
91. Gruenewald, D.A.; Matsumoto, A.M. Testosterone supplementation therapy for older men: potential benefits and risks. J. Am. Geriatr. Soc., 2003, 51(1), 101-115.
92. Matsumoto, A. M. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J. Gerontol. A Biol. Sci. Med. Sci., 2002, 57, 76-99.
93. Yu, B. P. Approaches to antiaging intervention: the promises and uncertainities. Mec. Age. Dev., 1999, 111, 73-87.
94. Sullivan, J.M. Estrogen replacement. Circulation 1996, 94, 2699-2702.
95. Craig, M.C.; Murphy, D.G. Oestrogen, cognition and the maturing female brain. J. Neuroendocrinol., 2007, 19, 1-6.
96. Berstein, L. M. Hormonal carcinogenesis. Nauka. St. Petersburg. Bioassays of phenformin for possible carcinogenicity. Cas no. 114- 86-3, NCI-CG-TR-7. 1977. NCI, Carcinogenesis, Technical Report Ser. No. 7, US DHEW Publ no. (NIH) 77-807, 2002.
97. IARC Monographs on the Evaluation of carcinogenic risks to humans, Suppl. 7. IARC, Lyon, 1987, pp. 319-320.
98. Lewis, M.C.; Orr, P.T.; Frick, K.M. Differential effects of acute progesterone administration on spatial and object memory in mid- dle-aged and aged female C57BL/6 mice. Horm. Behav., 2008, 54(3), 455-462.
99. Reiter, R.J. The ageing pineal gland and its physiological consequences. Bioessays, 1992, 14, 169-175.
100. Reiter, R.J.; Tan, D.X.; Mayo, J.C.; Sainz, R.M.; Lopez-Burillo, S. Melatonin, longevity and health in the aged: an assessment. Free Radic. Res., 2002, 36, 1323-1329.
101. Reiter, R.J.; Tan, D.X.; Burkhardt, S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech. Aging Dev., 2002, 30, 1007-1019.
102. Acuna-Castroviejo, D.; Escames, G.; Leon, J.; Carazo, A.; Khaldy, H. Mitochondrial regulation by melatonin and its metabolites. Adv. Exp. Med. Biol., 2003, 527, 549-557.
103. Haimov, I.; Lavie, P. Melatonin - a chronobiotic and soporific hormone. Arch. Gerontol. Geriatr., 1997, 24, 167-173.
104. Karasek, M. Melatonin, human aging, and age-related diseases. Exp. Gerontol., 2004, 39, 1723-9.
105. Anisimov, V.N.; Zavarzina, N.Y.; Zabezhinski, M.A.; Popovich, I.G.; Zimina, O.A.; Shtylick, A.V.; Arutjunyan, A.V.; Oparina, T.I.; Prokopenko, V.M.; Mikhalski, A.I.; Yashin, A.I. Melatonin increases both life span and tumor incidence in female CBA mice. J. Gerontol. A Biol. Sci. Med. Sci., 2001, 56(7), 311-323.
106. Osseni, R.A.; Rat, P.; Bogdan, A.; Warnet, J.M.; Touitou, Y. Evi- dence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci., 2000, 68(4), 387-399.
107. Barbieri, M.; Bonafe, M.; Franceschi, C.; Paolisso, G. Insulin/IGF- I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol. Metab., 2003, 285, 1064-1071.
108. Facchini, F.S.; Hua, N.; Abbasi, F.; Reaven, G.M. Insulin resis- tance as a predictor of age-related diseases. J. Clin. Endocrinol. Metab., 2001, 86, 3574-3578.
109. DeFronzo, R.A.; Ferrannini, E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular diseases. Diabetes Care, 1991, 14, 173-194.
110. Arai, Y.; Hirose, N.; Yamamura, K.; Shimizu, K.; Takayama, M.; Ebihara, Y.; Osono, Y. Serum insulin like growth factor 1(IGF-1) in centenarians: implication of IGF-1 as a turnover protein. J. Gerontol. A Biol. Sci. Med. Sci., 2001, 56, 79-82.
111. Paolisso, G.; Gambardella, A.; Ammendola, S.; D'Amore, A.; Varricchio, M. Glucose tolerance and insulin action in healthy centenarians. Am. J. Physiol. Endocrinol. Metab., 1996, 270, 890-896.
112. Arvat, E.; Broglo, F.; Ghigo, E. Insulin-like growth factor 1: implication in aging. Drugs Aging, 2000, 16, 29-40.
113. Sonntag, W.E.; Lynch, C.D.; Cefalu, W.T.; Ingram, R.L.; Bennet, S.A.; Thornton, P.; Khan, A.S. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric restricted animals. J. Gerontol. A Biol. Sci. Med. Sci., 1999, 54, 521-538.
114. Kaiser, U.; Schardt, C.; Brandscherdt, D.; Wollmer, E.; Havemann, K. Expression of insulin like growth factor receptors I and II in normal human breast and in lung cancer. J. Cancer. Res. Clin. Oncol., 1993, 119, 665-668.
115. McCay, C.M.; Crowell, M.F.; Maynard, L.A. The effect of retarded growth upon length of lifespan and upon ultimate body size. J. Nutr., 1935, 10, 63-79.
116. Weindruch, R.; Sohal, R.S. Caloric intake and aging. N. Engl. J. Med. 1997, 337, 986-994.
117. Masoro, E. J. Overview of caloric restriction and ageing. Mech. Ageing Dev., 2005, 126, 913-922.
118. Colman, R.J.; Anderson, R.M.; Johnson, S.C.; Kastman, E.K.; Kosmatka, K.J.; Beasley, T.M.; Allison, D.B.; Cruzen, C.; Simmons, H.A.; Kemnitz, J.W.; Weindruch, R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science, 2009, 325(5937), 201-204.
119. Mattson, M.P. Energy intake, meal frequency, and health: a neurobiological perspective. Annu. Rev. Nutr., 2005, 25, 237-260.
120. Guo, Z.; Mitchell-Raymundo, F.; Yang, H.; Ikeno, Y.; Nelson, J.; Diaz, V.; Richardson, A.; Reddick, R. Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficientmice. Mech. Ageing Dev., 2002, 123(8), 1121-1131.
121. Hursting, S.D.; Lavigne, J.A.; Berrigan, D.; Perkins, S.N.; Barrett, J.C. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu. Rev. Med., 2003, 54, 131-152.
122. Contestabile, A. Benefits of caloric restriction on brain aging and related pathological States: understanding mechanisms to devise novel therapies. Curr. Med. Chem. 2009, 16(3), 350-361.
123. Ershler, W.B.; Sun, W.H.; Binkley, N.; Gravenstein, S.; Volk, M.J.; Kamoske, G.; Klopp, R.G.; Roecker, E.B.; Daynes, R.A.; Weindruch, R. Interleukin 6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res., 1993, 12(4), 225-230.
124. Jolly, C.A. Dietary restriction and immune function. J. Nutr., 2004, 134,1853-1856.
125. Park, S.K.; Prolla, T.A. Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovasc. Res., 2005, 66, 205-212.
126. Straus, D.S. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J., 1994, 8, 6-12.
127. Weraarchakul, N.; Strong, R.; Wood, W.G.; Richardson, A. Effect of aging and dietary restriction on DNA repair. Exp. Cell Res., 1989, 181, 197-204.
128. Davis, L.J.; Hakim, G.; Masiello, P.; Novelli, M.; Bergamini, E.; Licastro, F. Plasma protein's glycation is decreasedin Sprague Dawley rats under caloric restriction. Arch. Gerontol. Geriatr., 1994, 19, 295-301.
129. Leeuwenburgh, C.; Wagner, P.; Holloszy, J.O.; Sohal, R.S.; Heinecke, J.W. Caloric restriction attenuates dityrosine dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice. Arch. Biochem. Biophys., 1997, 346, 74-80.
130. Dhahbi, J.M.; Kim, H.J.; Mote, P.L.; Beaver, R.J.; Spindler, S.R. Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc. Natl. Acad. Sci. USA, 2004, 101, 5524-5529.
131. Ingram, D.K.; Zhu, M.; Mamczarz, J.; Zou, S.; Lane, M.A.; Roth, G.S.; DeCabo, R. Calorie restriction mimetics: an emerging research field. Aging Cell, 2006, 5(2), 97-108.
132. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P.J.; Poosala, S.; Becker, K.G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K.W.; Spencer, R.G.; Lakatta, E.G.; Le Couteur, D.; Shaw, R.J.; Navas, P.; Puigserver, P.; Ingram, D.K.; De Cabo, R.; Sinclair, D.A. Reseveratrol improves health and survival of mice on a high calorie diet. Nature, 2006, 444, 337-342.
133. Guarente, L.; Picard, F. Calorie restriction-the SIR2 connection. Cell, 2005, 120, 473-482.
134. Hekimi, S.; Guarente, L. Genetics and the specificity of the aging process. Science, 2003, 299, 1351-1354.
135. Martin, G.M.; Bergman, A.; Barzilai, N. Genetic determinants of human health span and life span. PLoS Genet. 2007, 3(7), e125.
136. Jazwinski, S.M. Aging and longevity genes. Acta. Biochim. Pol., 2000, 47(2), 269-279.
137. Singh, R.; Kolvraa, S.; Rattan, S.I. Genetics of longevity with emphasis on the relevance of HSP70 genes. Front. Biosci., 2007, 12, 4504-4513.
138. Christensen, K.; Johnson, T.E.; Vaupel, J.W. The quest for genetic determinants of human longevity: challenges and insights. Nature Rev. Genet., 2006, 7, 436-448.
139. Ratan, S.I.; Singh, R. Progress and Prospects: Gene therapy in aging. Gene Therapy 2009, 16, 3-9.
140. Longo, V.D. The race to control aging and disease. Biochemist., 2008, 30, 8-13.
141. Schriner, S.E.; Linford, N.J. Extension of mouse lifespan by over-expression of catalase. Age, 2006, 28, 209-218.
142. Sohal, R.S.; Agarwal, A.; Agarwal, S.; Orr, W.C. Simultaneous overexpression of copper-and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J. Biol. Chem., 1995, 270(26), 15671-15674.
143. Schriner, S.E.; Linford, N.J.; Martin, G.M.; Treuting, P.; Ogburn, C.E.; Emond, M.; Coskun, P.E.; Ladiges, W.; Wolf, N.; Van Remmen, H.; Wallace, D.C.; Rabinovitch, P.S. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 2005, 308(5730), 1909-1911.
144. Hsu, A.; Murphy, C.T.; Kenyon, C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science, 2003, 300(5622), 1142-1145.
145. Wang, H.D.; Kazemi-Esfarjani, P.; Benzer, S. Multiple-stress analysis for isolation of Drosophila longevity genes. Proc. Natl. Acad. Sci. USA, 2004, 101(34), 12610-12615.
146. Bluher, M.; Kahn, B.B.; Kahn, C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science, 2003, 299(5606), 572-574.
147. Kurosu, H.; Yamamoto, M.; Clark, J.D.; Pastor, J.V.; Nandi, A.; Gurnani, P.; McGuinness, O.P.; Chikuda, H.; Yamaguchi, M.; Kawaguchi, H.; Shimomura, I.; Takayama, Y.; Herz, J.; Kahn, C.R.; Rosenblatt, K.P.; Kuro-o, M. Suppression of aging in mice by the hormone Klotho. Scienc, 2005, 309(5742), 1829-1833.
148. Cong, Y.S.; Wright, W.E.; Shay, J.W. Human Telomerase and Its Regulation. Microbiol. Mol. Biol. Rev., 2002, 66(3), 407-425.
149. Takubo, K.; Izumiyama-Shimomura, N.; Honma, N.; Sawabe, M.; Arai, T.; Kato, M.; Oshimura M, Nakamura K. Telomere length are characteristic in each human individual. Exp. Gerontol., 2002, 37, 523-531.
150. Cawthon, R.M.; Smith, K.R.; O'Brien, E.; Sivatchenko, A.; Kerber, R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet, 2003, 361, 393-395.
151. Hiyama, K.; Hirai, Y.; Kyoizumi, S.; Akiyama, M.; Piatyszek, M.A.; Shay, J.W.; Shay, J.W.; Ishioka, S.; Yamakido, M. Activation of telomerase in human lympocytes and hematopoietic progenitor cells. J. Immunol., 1995, 155, 3711-3715.
152. Remes, K.; Norrback, K.F.; Rosenquist, R.; Mehle, C.; Lindh, J.; Roos, G. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br. J. Cancer, 2000, 82, 601-607.
153. Weissman, I.L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science, 2000, 287, 1442-14426.
154. Thomson, J.A.; Itskovitz-Eldor, J.; Shapiro, S.S.; Waknitz, M.A.; Swiergiel, J.J.; Marshall, V.S.; Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282(5391), 1145-1147.
155. Ho, A.D.; Punzel, M. Hematopoietic stem cells: can old cells learn new tricks? J. Leukoc. Biol., 2003, 73, 547-555.
156. Rando, T.A. Stem cells, ageing and the quest for immortality. Nature, 2006, 441(7097), 1080-1086.
157. Conboy, I.M.; Conboy, M.J.; Wagers, A.J.; Girma, E.R.; Weissman, I.L.; Rando, T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature, 2005, 433, 760-764.
158. Thomas, E.D.; Flournoy, N.; Buckner, C.D.; Clift, R.A.; Fefer, A.; Neimen, P.E.; Storb, R. Cure of leukemia by marrow transplantation. Leuk. Res., 1977, 1, 67-70.
159. Min, J.Y.; Chen, Y.; Sohail Malek, B.S.; Meissner, A.; Xiang, M.; KQ, A.; Feng, X.; Nakayama, M.; Kaplan, E.; Morgan, J.P. Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis. J. Thorac. Cardiovasc. Surg., 2005, 130, 547-553.